Skip Page Header

Home > Global report on access to hepatitis C treatment - Focus on overcoming barriers.

World Health Organization. (2016) Global report on access to hepatitis C treatment - Focus on overcoming barriers. Geneva: World Health Organization.

[img]
Preview
PDF (WHO Global report on access to hepatitis C treatment)
1MB

This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome. It also provides information on the production of new hepatitis C drugs and generic versions worldwide, including where the drugs are registered, where the drugs are patented and where not, and what opportunities countries have under the license agreements that were signed by some companies as well as current pricing of all recommended direct-acting antivirals (DAAs), including by generic companies all over the world.

P.12 - People who inject drugs (PWID) are the group with the highest HCV prevalence, an estimated 67%. Injections among PWID with unsterilized syringes or shared injecting equipment are the major transmission mode in high-income countries and are increasingly being reported in LMICs (low- and middle-income countries). The major route of transmission in LMICs is through the reuse of syringes and needles, and through substandard infection control practices in health-care settings.


Item Type
Report
Publication Type
International, Report
Drug Type
Substances (not alcohol/tobacco), Opioid
Intervention Type
Harm reduction
Source
Date
October 2016
Pages
68 p.
Publisher
World Health Organization
Corporate Creators
World Health Organization
Place of Publication
Geneva
EndNote

Repository Staff Only: item control page